Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Ironwood Pharmaceuticals Inc., 3 years.
Ironwood Pharmaceuticals Inc.
Director
MoonLake Immunotherapeutics
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 2026 | Ironwood Pharmaceuticals Inc. | Grant or award | +63,481 | — | — |
| Jul 3, 2025 | MoonLake Immunotherapeutics | Option exercise | +23,500 | — | — |
| Jul 3, 2025 | MoonLake Immunotherapeutics | Open-market sale | −23,500 | $48.79 | $1,146,565 |
| Jun 10, 2025 | Ironwood Pharmaceuticals Inc. | Grant or award | +45,000 | — | — |
| Jun 18, 2024 | Ironwood Pharmaceuticals Inc. | Grant or award | +24,311 | — | — |
| Jun 7, 2024 | Ironwood Pharmaceuticals Inc. | Open-market sale | −35,574 | $6.61 | $235,144 |
| Jun 6, 2024 | Ironwood Pharmaceuticals Inc. | Open-market sale | −44,426 | $6.36 | $282,549 |
| Dec 15, 2023 | Ironwood Pharmaceuticals Inc. | Grant or award | +1,572 | — | — |
| Sep 15, 2023 | Ironwood Pharmaceuticals Inc. | Grant or award | +2,098 | — | — |
| Jun 20, 2023 | Ironwood Pharmaceuticals Inc. | Grant or award | +22,350 | — | — |
| Jun 15, 2023 | Ironwood Pharmaceuticals Inc. | Grant or award | +1,586 | — | — |
| Mar 15, 2023 | Ironwood Pharmaceuticals Inc. | Grant or award | +1,677 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.